Literature DB >> 35372899

Dialysis Filter Life in COVID-19: Early Lessons from the Pandemic.

Ignacio Portales-Castillo1, Andrew S Allegretti1.   

Abstract

Entities:  

Keywords:  COVID-19; CRRT; CVVH; SARS; SARS-CoV-2; acute kidney injury; acute kidney injury and ICU nephrology; continuous venovenous hemofiltration; coronavirus; end stage renal disease; hemodialysis; hemofiltration; hypercoagulability; thrombosis

Mesh：

Year:  2020        PMID： 35372899      PMCID： PMC8815521          DOI： 10.34067/KID.0006212020

Source DB:  PubMed          Journal:  Kidney360        ISSN： 2641-7650


× No keyword cloud information.
  17 in total

1.  Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.

Authors:  Ning Tang; Huan Bai; Xing Chen; Jiale Gong; Dengju Li; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-04-27       Impact factor: 5.824

2.  Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy: A Single-Center Experience.

Authors:  Divya Shankaranarayanan; Thangamani Muthukumar; Tarek Barbar; Aarti Bhasin; Supriya Gerardine; Perola Lamba; Lorenz Leuprecht; Sanjay P Neupane; Thalia Salinas; Daniil Shimonov; Elly Varma; Frank Liu
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-17       Impact factor: 8.237

3.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.

Authors:  Giacomo Grasselli; Massimiliano Greco; Alberto Zanella; Giovanni Albano; Massimo Antonelli; Giacomo Bellani; Ezio Bonanomi; Luca Cabrini; Eleonora Carlesso; Gianpaolo Castelli; Sergio Cattaneo; Danilo Cereda; Sergio Colombo; Antonio Coluccello; Giuseppe Crescini; Andrea Forastieri Molinari; Giuseppe Foti; Roberto Fumagalli; Giorgio Antonio Iotti; Thomas Langer; Nicola Latronico; Ferdinando Luca Lorini; Francesco Mojoli; Giuseppe Natalini; Carla Maria Pessina; Vito Marco Ranieri; Roberto Rech; Luigia Scudeller; Antonio Rosano; Enrico Storti; B Taylor Thompson; Marcello Tirani; Pier Giorgio Villani; Antonio Pesenti; Maurizio Cecconi
Journal:  JAMA Intern Med       Date:  2020-10-01       Impact factor: 21.873

4.  Perspectives of continuous renal replacement therapy in the intensive care unit: a paired survey study of patient, physician, and nurse views.

Authors:  Andrew S Allegretti; Gregory Hundemer; Rajeev Chorghade; Katherine Cosgrove; Ednan Bajwa; Ishir Bhan
Journal:  BMC Nephrol       Date:  2015-07-14       Impact factor: 2.388

5.  Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.

Authors:  Chao Liu; Zhi Mao; Hongjun Kang; Jie Hu; Feihu Zhou
Journal:  Crit Care       Date:  2016-05-13       Impact factor: 9.097

Review 6.  Cytokine removal in human septic shock: Where are we and where are we going?

Authors:  Patrick M Honore; Eric Hoste; Zsolt Molnár; Rita Jacobs; Olivier Joannes-Boyau; Manu L N G Malbrain; Lui G Forni
Journal:  Ann Intensive Care       Date:  2019-05-14       Impact factor: 6.925

Review 7.  Clinical review: Patency of the circuit in continuous renal replacement therapy.

Authors:  Michael Joannidis; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

8.  Continuous renal replacement therapy outcomes in acute kidney injury and end-stage renal disease: a cohort study.

Authors:  Andrew S Allegretti; David J R Steele; Jo Ann David-Kasdan; Ednan Bajwa; John L Niles; Ishir Bhan
Journal:  Crit Care       Date:  2013-06-20       Impact factor: 9.097

9.  Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.

Authors:  Yuvaram N V Reddy; Rochelle P Walensky; Mallika L Mendu; Nathaniel Green; Krishna P Reddy
Journal:  Am J Kidney Dis       Date:  2020-07-28       Impact factor: 8.860

10.  COVID-19 and its implications for thrombosis and anticoagulation.

Authors:  Jean M Connors; Jerrold H Levy
Journal:  Blood       Date:  2020-06-04       Impact factor: 25.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.